188 related articles for article (PubMed ID: 22515093)
21. Spectroscopic studies and photodynamic actions of hypocrellin B in liposomes.
Yu C; Chen S; Zhang M; Shen T
Photochem Photobiol; 2001 May; 73(5):482-8. PubMed ID: 11367568
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy induced Fas-mediated apoptosis in human carcinoma cells.
Ali SM; Chee SK; Yuen GY; Olivo M
Int J Mol Med; 2002 Mar; 9(3):257-70. PubMed ID: 11836632
[TBL] [Abstract][Full Text] [Related]
23. Delivering a hydrophobic anticancer drug for photodynamic therapy by amorphous formulation.
Zhou L; Wang W; Feng Y; Wei S; Zhou J; Yu B; Shen J
Bioorg Med Chem Lett; 2010 Nov; 20(21):6172-4. PubMed ID: 20850314
[TBL] [Abstract][Full Text] [Related]
24. 808 nm Light-triggered and hyaluronic acid-targeted dual-photosensitizers nanoplatform by fully utilizing Nd(3+)-sensitized upconversion emission with enhanced anti-tumor efficacy.
Hou Z; Deng K; Li C; Deng X; Lian H; Cheng Z; Jin D; Lin J
Biomaterials; 2016 Sep; 101():32-46. PubMed ID: 27267626
[TBL] [Abstract][Full Text] [Related]
25. Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles.
Chang JE; Cho HJ; Jheon S
J Vis Exp; 2016 Dec; (118):. PubMed ID: 27929475
[TBL] [Abstract][Full Text] [Related]
26. Preclinical assessment of hypocrellin B and hypocrellin B derivatives as sensitizers for photodynamic therapy of cancer: progress update.
Miller GG; Brown K; Ballangrud AM; Barajas O; Xiao Z; Tulip J; Lown JW; Leithoff JM; Allalunis-Turner MJ; Mehta RD; Moore RB
Photochem Photobiol; 1997 Apr; 65(4):714-22. PubMed ID: 9114749
[TBL] [Abstract][Full Text] [Related]
27. Biodegradable hypocrellin derivative nanovesicle as a near-infrared light-driven theranostic for dually photoactive cancer imaging and therapy.
Zheng X; Ge J; Wu J; Liu W; Guo L; Jia Q; Ding Y; Zhang H; Wang P
Biomaterials; 2018 Dec; 185():133-141. PubMed ID: 30243149
[TBL] [Abstract][Full Text] [Related]
28. Effect of PEG-PDLLA polymeric nanovesicles loaded with doxorubicin and hematoporphyrin monomethyl ether on human hepatocellular carcinoma HepG2 cells in vitro.
Xiang GH; Hong GB; Wang Y; Cheng D; Zhou JX; Shuai XT
Int J Nanomedicine; 2013; 8():4613-22. PubMed ID: 24324333
[TBL] [Abstract][Full Text] [Related]
29. Natural-Origin Hypocrellin-HSA Assembly for Highly Efficient NIR Light-Responsive Phototheranostics against Hypoxic Tumors.
Zhang C; Wu J; Liu W; Zheng X; Wang P
ACS Appl Mater Interfaces; 2019 Dec; 11(48):44989-44998. PubMed ID: 31755268
[TBL] [Abstract][Full Text] [Related]
30. Chemo-photodynamic antitumour therapy based on Er-doped upconversion nanoparticles coated with hypocrellin B and MnO
Lan J; Chen S; Chen Z; Luo D; Yu C; Zeng L; Sun W; Zhang X; Yao X; Wu F; Chen J
Biomater Adv; 2024 Jul; 161():213891. PubMed ID: 38781738
[TBL] [Abstract][Full Text] [Related]
31. Uptake kinetics and intracellular localization of hypocrellin photosensitizers for photodynamic therapy: a confocal microscopy study.
Miller GG; Brown K; Moore RB; Diwu ZJ; Liu J; Huang L; Lown JW; Begg DA; Chlumecky V; Tulip J
Photochem Photobiol; 1995 Jun; 61(6):632-8. PubMed ID: 7568409
[TBL] [Abstract][Full Text] [Related]
32. Preparation of gelatin nanoparticles by two step desolvation method for application in photodynamic therapy.
Carvalho JA; Abreu AS; Ferreira VTP; Gonçalves EP; Tedesco AC; Pinto JG; Ferreira-Strixino J; Beltrame Junior M; Simioni AR
J Biomater Sci Polym Ed; 2018 Aug; 29(11):1287-1301. PubMed ID: 29561222
[TBL] [Abstract][Full Text] [Related]
33. External heavy-atomic construction of photosensitizer nanoparticles for enhanced in vitro photodynamic therapy of cancer.
Zhou L; Wei S; Ge X; Zhou J; Yu B; Shen J
J Phys Chem B; 2012 Oct; 116(42):12744-9. PubMed ID: 22984941
[TBL] [Abstract][Full Text] [Related]
34. Quantitative and site-directed chemical modification of hypocrellins toward direct drug delivery and effective photodynamic activity.
Deng H; Liu X; Xie J; Yin R; Huang N; Gu Y; Zhao J
J Med Chem; 2012 Mar; 55(5):1910-9. PubMed ID: 22352922
[TBL] [Abstract][Full Text] [Related]
35. Biophysical evaluation of two red-shifted hypocrellin B derivatives as novel PDT agents.
Paul BT; Babu MS; Santhoshkumar TR; Karunagaran D; Selvam GS; Brown K; Woo T; Sharma S; Naicker S; Murugesan R
J Photochem Photobiol B; 2009 Jan; 94(1):38-44. PubMed ID: 18977666
[TBL] [Abstract][Full Text] [Related]
36. Hypocrellin B-encapsulated nanoparticle-mediated rev-caspase-3 gene transfection and photodynamic therapy on tumor cells.
Bai D; Xia X; Yow CM; Chu ES; Xu C
Eur J Pharmacol; 2011 Jan; 650(2-3):496-500. PubMed ID: 20970418
[TBL] [Abstract][Full Text] [Related]
37. Novel surfactant-like hypocrellin derivatives to achieve simultaneous drug delivery in blood plasma and cell uptake.
Zhang Y; Song L; Xie J; Qiu H; Gu Y; Zhao J
Photochem Photobiol; 2010; 86(3):667-72. PubMed ID: 20331522
[TBL] [Abstract][Full Text] [Related]
38. Hypocrellins as photosensitizers for photodynamic therapy: a screening evaluation and pharmacokinetic study.
Estey EP; Brown K; Diwu Z; Liu J; Lown JW; Miller GG; Moore RB; Tulip J; McPhee MS
Cancer Chemother Pharmacol; 1996; 37(4):343-50. PubMed ID: 8548880
[TBL] [Abstract][Full Text] [Related]
39. Near-Infrared Hypocrellin Derivatives for Synergistic Photodynamic and Photothermal Therapy.
Ding Y; Liu W; Wu J; Zheng X; Ge J; Ren H; Zhang W; Lee CS; Wang P
Chem Asian J; 2020 Nov; 15(21):3462-3468. PubMed ID: 32909355
[TBL] [Abstract][Full Text] [Related]
40. Hypocrellin B and nano silver loaded polymeric nanoparticles: Enhanced generation of singlet oxygen for improved photodynamic therapy.
Natesan S; Krishnaswami V; Ponnusamy C; Madiyalakan M; Woo T; Palanisamy R
Mater Sci Eng C Mater Biol Appl; 2017 Aug; 77():935-946. PubMed ID: 28532114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
